Mark Schoenberg - 20 Jan 2023 Form 4 Insider Report for UroGen Pharma Ltd. (URGN)

Role
Chief Medical Officer
Signature
/s/ Jason D. Smith, Attorney-in-Fact
Issuer symbol
URGN
Transactions as of
20 Jan 2023
Net transactions value
+$613,385
Form type
4
Filing time
23 Jan 2023, 18:10:39 UTC
Previous filing
02 Nov 2022
Next filing
02 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction URGN Ordinary Shares Options Exercise $613,385 +122,677 +512% $5.00* 146,627 20 Jan 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction URGN Employee Stock Option (right to buy) Options Exercise $0 -122,677 -100% $0.000000* 0 20 Jan 2023 Ordinary Shares 122,677 $5.00 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.